[Therapy of primary sclerosing cholangitis]

Praxis (Bern 1994). 2000 May 31;89(22):975-7.
[Article in German]

Abstract

In primary sclerosing cholangitis the aim of treatment is a reduction of the inflammatory destruction of the bile ducts leading to cholestasis and irreversible liver damage. Treatment with ursodeoxycholic acid may decrease the periductular inflammation. Bacterial infection of the bile ducts is frequent and should be treated by antibiotics. Medical treatment of the disease may be successful under the assumption that dominant stenoses are treated endoscopically.

Publication types

  • English Abstract

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Infections / therapy
  • Cholangitis, Sclerosing / etiology
  • Cholangitis, Sclerosing / therapy*
  • Combined Modality Therapy
  • Endoscopy
  • Humans
  • Ursodeoxycholic Acid / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Ursodeoxycholic Acid